Skip to content
Clinical Trials – home

Octreotide Acetate: A Comprehensive Guide for Patients

3 / 5
trials open to patients / all trials
15+
Countries

In short

Octreotide Acetate, a synthetic analog of somatostatin, is being studied in various clinical trials for its potential benefits in treating different medical conditions. These trials aim to evaluate its efficacy, safety, and tolerability in patients with acromegaly, neuroendocrine tumors, liver cancer, and other conditions. The research focuses on different formulations and administration methods of Octreotide Acetate, including long-acting release (LAR) versions and implants, to improve patient outcomes and quality of life.

At a glance

Drug Name
Octreotide Acetate
Conditions Studied
Acromegaly, Neuroendocrine Tumors, Liver Cancer, Diarrhea, Liver Transplantation Complications
Administration Methods
Subcutaneous, Intramuscular, Intravenous, Implants
Formulations
Short-acting, Long-acting Release (LAR), Implants
Primary Outcomes
Hormone level reduction, Symptom control, Tumor response, Renal function improvement
Secondary Outcomes
Safety profile, Quality of life, Progression-free survival, Blood loss reduction
Potential Benefits
Hormone regulation, Tumor growth control, Symptom management, Improved surgical outcomes
Safety Monitoring
Adverse events, Blood sugar levels, Heart rhythm, Injection site reactions

What is Octreotide Acetate?

Octreotide Acetate is a medication that belongs to a class of drugs called somatostatin analogs. It is also known by other names such as Sandostatin, SMS995, and Siroctid . This medication is designed to mimic the effects of somatostatin, a natural hormone in your body that regulates various functions, particularly in the digestive system and certain glands.

Conditions Treated with Octreotide Acetate

Octreotide Acetate is used to treat several medical conditions, including:

  • Acromegaly: A hormonal disorder that results from the production of too much growth hormone, leading to abnormal growth of body tissues
  • Neuroendocrine Tumors (NETs): Rare tumors that can occur in various parts of the body, particularly in the digestive system or lungs
  • Carcinoid Syndrome: A group of symptoms associated with certain types of NETs
  • Pancreatic Fistula: A complication that can occur after pancreatic surgery
  • Diarrhea associated with certain medications: For example, diarrhea caused by mycophenolate mofetil, an immunosuppressant drug

How Octreotide Acetate Works

Octreotide Acetate works by mimicking the action of somatostatin in the body. It helps to:

  • Reduce the production of certain hormones, such as growth hormone and insulin-like growth factor 1 (IGF-1) in acromegaly patients
  • Slow down the growth of tumors in patients with neuroendocrine tumors
  • Control symptoms associated with carcinoid syndrome, such as flushing and diarrhea
  • Reduce pancreatic secretions, which can help in preventing or treating pancreatic fistulas

How Octreotide Acetate is Administered

Octreotide Acetate can be administered in several ways:

  • Short-acting injections: Given subcutaneously (under the skin) multiple times a day
  • Long-acting release (LAR) formulations: Given as intramuscular injections every 28 days
  • Implants: Subcutaneous implants that release the medication over an extended period
  • Experimental formulations: Such as Debio 4126, a 12-week prolonged-release formulation being studied in clinical trials

Ongoing Research and Clinical Trials

Researchers are continuously studying Octreotide Acetate to understand its effects better and explore new potential uses. Some areas of ongoing research include:

  • Its impact on the immune system in patients with neuroendocrine tumors
  • Long-term safety and efficacy in treating acromegaly
  • Comparison with other medications like somatostatin in preventing pancreatic fistulas after surgery
  • Its potential use in treating polycystic kidney disease
  • Its effectiveness in treating advanced liver cancer

Potential Side Effects and Safety Considerations

Like all medications, Octreotide Acetate can cause side effects. Common side effects may include:

  • Gastrointestinal symptoms such as diarrhea, nausea, or abdominal pain
  • Injection site reactions
  • Changes in blood sugar levels
  • Gallbladder problems

It's important to note that the safety and tolerability of Octreotide Acetate are continually being evaluated in clinical trials . Your healthcare provider will monitor you closely while you're on this medication and adjust the dosage as needed to minimize side effects while maximizing benefits.

Questions people often ask

Conditions where Octreotide Acetate is being studied

Each condition opens its own overview and trial list

Trials with Octreotide Acetate

Recruiting trials first

See all 5 →
Quick filters
  • Participants:All ages
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.